Tradestie Institutional Equity Comparison Engine

HCM vs BMM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HCM Overall Edge

HCM Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to HUTCHMED (China) Limited American Depositary Shares (HCM) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, HCM trades at N/M Forward P/E with -6.3% operating margin (+0.2% YoY revenue) versus BMM at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HCM sits in UNCLASSIFIED (73rd %ile IV; Dealer Gamma Walls on Pro) against BMM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner HCM
HCM N/M vs BMM N/M Fwd P/E
Growth & Margin Winner HCM
Op Margin -6.3% vs N/A ยท YoY +0.2% vs N/A
Momentum & Technical Winner HCM
1Y -9.8% vs -44.7% ยท 52W Pos 53% vs 0%
Options & Structure Winner HCM
UNCLASSIFIED (73rd %ile IV) vs UNCLASSIFIED (N/A IV)
HCM NASDAQ
HUTCHMED (China) Limited American Depositary Shares
Pharmaceutical Preparations
$13.22
-1.71% 1D
Market Cap $2.3B
1M Return -7.42%
1Y Return -9.82%
Forward P/E N/M
Unified AI Score
38.1 / 100 SELL
Tech 31.0 Fund 44.0 Flow 50.0 Mom 56.0
BMM US Equity
BMM
Institutional Equity
$2.50
-8.42% 1D
Market Cap N/A
1M Return -36.55%
1Y Return -44.69%
Forward P/E N/M
Unified AI Score
38.2 / 100 SELL
Tech 25.0 Fund 39.0 Flow 50.0 Mom 34.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HCM -9.82% BMM -44.69% Spread: +29.6 pp (HCM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HCM TTM Op. Margin: -6.3% BMM TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HCM vs BMM. Trailing 12-month operating profitability (HCM -6.3% vs BMM N/A) and valuation multiples (HCM N/M vs BMM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HCM (8) vs BMM (0)
Institutional Metric HCM BMM Criterion Row Winner
Market Capitalization Scale $2.3B N/A Larger Scale HCM
Trailing P/E Ratio Valuation 134.0x N/M Lower Multiple HCM
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.2% N/A Higher Growth HCM
Operating Margin (TTM) Profitability -6.3% N/A Higher Margin HCM
Net Profit Margin Profitability 3.3% N/A Higher Margin HCM
Return on Equity (ROE) Capital Efficiency 1.5% N/A Higher ROE HCM
52-Week Range Position Momentum 53% ($10โ€“$16) 0% ($2โ€“$9) Stronger Trend HCM
Beta / 30D Volatility Risk Regime 0.64ฮฒ ยท 45% Vol 2.19ฮฒ ยท 100% Vol Lower Realized Risk HCM
Unified Institutional Score Composite Signal 38.1 / 100 (SELL) 38.2 / 100 (SELL) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HCM vs BMM Buy Guide
HCM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 73rd %ile
IV Regime Elevated (60thโ€“80th %ile)
Live HCM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BMM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HCM nor BMM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.